© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists
ORIGINAL ARTICLE
Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer
1 Department of Genetics, Portuguese Oncology Institute-Porto, Rua Dr António Bernardino de Almeida, 4200-072 Porto, Portugal
2 Department of Pathology, Portuguese Oncology Institute-Porto
3 Department of Urology, Portuguese Oncology Institute-Porto
4 Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar, University of Porto, Largo Prof. Abel Salazar 2, 4099-003 Porto, Portugal
Correspondence to:
Correspondence to:
Dr C Jerónimo
Department of Genetics, Portuguese Oncology Institute, Rua Dr António Bernardino de Almeida, 4200-072 Porto, Portugal; cjeronimo{at}hotmail.com
Aims: Retinoids are involved in cell growth, differentiation, and carcinogenesis. Their effects depend on cytosolic transport and binding to nuclear receptors. CRBP1 encodes a protein involved in this process. Because altered CRBP1 expression and promoter hypermethylation occur in several tumours, these changes were investigated in prostate tumorigenesis.
Methods: The CRBP1 promoter was assessed by methylation specific polymerase chain reaction on tissue samples from 36 radical prostatectomy specimens (paired normal tissue, adenocarcinoma, and high grade prostatic intraepithelial neoplasia (HGPIN)), 32 benign prostatic hyperplasias (BPHs), and 13 normal prostate tissue samples from cystoprostatectomies. Methylation of DNA extracted from microdissected tissue was examined blindly. CRBP1 expression was assessed by immunohistochemistry on formalin fixed, paraffin wax embedded tissue.
Results: Loss of CRBP1 expression was seen in 15 of 36 adenocarcinomas and 18 of 36 HGPINs. Fifteen adenocarcinomas and nine HGPINs showed overexpression, whereas the remainder showed normal expression. BPH displayed normal expression. No significant associations were found between CRBP1 expression and Gleason score or stage. CRBP1 promoter hypermethylation was found in 17 of 36 adenocarcinomas, three of 35 HGPINs, one of 36 normal prostate tissues from the same patients, none of 32 BPHs, and none of 13 normal prostate tissues from cystoprostatectomies. Loss of expression and hypermethylation of CRBP1 were not significantly associated.
Conclusions: Altered CRBP1 expression and hypermethylation are common in prostate carcinoma, although CRBP1 hypermethylation is not an early event in tumorigenesis. Moreover, both adenocarcinoma and HGPIN show frequent CRBP1 overexpression. The molecular mechanisms underlying altered CRBP1 expression in prostate cancer deserve further study.
Abbreviations: BPH, benign prostatic hyperplasia; CRBP, cellular retinol binding protein; HGPIN, high grade prostatic intraepithelial neoplasia; LOH, loss of heterozygosity; MSP, methylation specific polymerase chain reaction; PBS, phosphate buffered saline; PCa, prostate carcinoma; PCR, polymerase chain reaction; PIN, prostatic intraepithelial neoplasia; PSA, prostate specific antigen
Keywords: CRBP1; prostate cancer; PIN; methylation; immunoexpression
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Schenk, J. M., Riboli, E., Chatterjee, N., Leitzmann, M. F., Ahn, J., Albanes, D., Reding, D. J., Wang, Y., Friesen, M. D., Hayes, R. B., Peters, U.
(2009). Serum Retinol and Prostate Cancer Risk: a Nested Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol. Biomarkers Prev.
18: 1227-1231
[Abstract] [Full Text] -
Murphy, T M, Perry, A S, Lawler, M
(2008). The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer. Endocr Relat Cancer
15: 11-25
[Abstract] [Full Text] -
Perry, A. S, Foley, R., Woodson, K., Lawler, M.
(2006). The emerging roles of DNA methylation in the clinical management of prostate cancer.. Endocr Relat Cancer
13: 357-377
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
